Subscriptions: Want to stay updated? Click here to subscribe to our press releases
Dec | Nov | Oct | Sep | Aug | Jul | Jun | May | Apr | Mar | Feb  | Jan

	Q1 - FY03 Results; Dr. Reddy's revenue up 51% to Rs.4533 million July 31, 2002
	Ragaglitazar (DRF 2725) clinical development suspended July 22, 2002
	Dr. Reddy's announces ANDA filing for Terbinafine HCl Tablets July 19, 2002
	Dr Reddy's announces USFDA approval for Ciprofloxacin July 10, 2002
	Dr. Reddy's announces USFDA approval for Tizanidine HCL tablets July 3, 2002

The information contained in the releases was current on the date they were issued and will become or may have become outdated over time. Dr. Reddy's does not assume any responsibility for updating
information in the releases.